Proopiomelanocortin Neurons

Proopiomelanocortin Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Proopiomelanocortin Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Hypothalamic Neurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Arcuate nucleus of hypothalamus</td>
</tr>
<tr>
<td class="label">Cell Types</td>
<td>POMC-expressing neurons, POMC/AgRP neurons</td>
</tr>
<tr>
<td class="label">Neurotransmitters</td>
<td>alpha-MSH, ACTH, beta-endorphin</td>
</tr>
<tr>
<td class="label">Receptors</td>
<td>MC3R, MC4R, leptin receptor, insulin receptor</td>
</tr>
</table>

Proopiomelanocortin (POMC) [neurons](/entities/neurons) are critical hypothalamic neurons that produce alpha-melanocyte-stimulating hormone (alpha-MSH), adrenocorticotropic hormone (ACTH), and beta-endorphin. These neurons play essential roles in energy homeostasis, appetite regulation, stress response, and neuroimmune modulation. POMC dysfunction has been implicated in neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and ALS. [@hypothalamic]

Overview

Proopiomelanocortin Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Proopiomelanocortin Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Hypothalamic Neurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Arcuate nucleus of hypothalamus</td>
</tr>
<tr>
<td class="label">Cell Types</td>
<td>POMC-expressing neurons, POMC/AgRP neurons</td>
</tr>
<tr>
<td class="label">Neurotransmitters</td>
<td>alpha-MSH, ACTH, beta-endorphin</td>
</tr>
<tr>
<td class="label">Receptors</td>
<td>MC3R, MC4R, leptin receptor, insulin receptor</td>
</tr>
</table>

Proopiomelanocortin (POMC) [neurons](/entities/neurons) are critical hypothalamic neurons that produce alpha-melanocyte-stimulating hormone (alpha-MSH), adrenocorticotropic hormone (ACTH), and beta-endorphin. These neurons play essential roles in energy homeostasis, appetite regulation, stress response, and neuroimmune modulation. POMC dysfunction has been implicated in neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and ALS. [@hypothalamic]

Overview

Molecular Biology

POMC neurons express the POMC gene, which is processed into multiple bioactive peptides through tissue-specific cleavage by prohormone convertases (PC1/3 and PC2). The POMC precursor yields: [@metabolica]

• alpha-MSH: Anorexigenic peptide acting on melanocortin receptors MC3R and MC4R
• ACTH: Regulates cortisol release from adrenal glands
• beta-Endorphin: Endogenous opioid peptide

Normal Function

Energy Homeostasis

POMC neurons are central to energy balance regulation: [@hpaa]

• Anorexigenic signaling: alpha-MSH released from POMC neurons activates MC4R in the paraventricular nucleus (PVN), promoting satiety
• Leptin sensitivity: Leptin from adipocytes stimulates POMC neuronal activity, reducing food intake
• Glucose metabolism: POMC neurons regulate hepatic glucose production and pancreatic insulin secretion

Stress Response

Through ACTH release, POMC neurons activate the hypothalamic-pituitary-adrenal (HPA) axis: [@mcr]

• ACTH stimulates cortisol release from the adrenal [cortex](/brain-regions/cortex)
• Cortisol provides metabolic energy during stress
• Beta-endorphin modulates pain perception and mood

Neuroimmune Modulation

POMC-derived peptides have immunomodulatory properties: [@leptina]

• alpha-MSH exerts anti-inflammatory effects via MC1R on immune cells
• ACTH can modulate lymphocyte function
• The POMC system interacts with [microglia](/cell-types/microglia-neuroinflammation) in CNS immune responses

Role in Neurodegenerative Diseases

Alzheimer's Disease

POMC neurons are affected in AD through multiple mechanisms: [@intranasal]

Hypothalamic dysfunction: AD is associated with hypothalamic atrophy and altered POMC function. Studies show reduced POMC expression in AD brains, impaired leptin signaling and leptin resistance, and altered cortisol rhythms with HPA axis dysregulation [1](https://pubmed.ncbi.nlm.nih.gov/31345892/) [2](https://pubmed.ncbi.nlm.nih.gov/32861326/) [3](https://pubmed.ncbi.nlm.nih.gov/22094460/).

Metabolic dysfunction: Metabolic syndrome increases AD risk. Insulin resistance and type 2 diabetes are AD risk factors. POMC neurons regulate insulin sensitivity and leptin dysfunction may contribute to amyloid pathology [4](https://pubmed.ncbi.nlm.nih.gov/31345892/).

Neuroinflammation: POMC peptides modulate neuroinflammation. alpha-MSH has anti-inflammatory properties in the brain. Loss of POMC function may exacerbate microglial activation and AD shows increased pro-inflammatory cytokines affecting hypothalamic neurons [5](https://pubmed.ncbi.nlm.nih.gov/30658626/).

Parkinson's Disease

POMC abnormalities in PD include:

Non-motor symptoms: PD involves hypothalamic dysfunction. Sleep disorders (REM sleep behavior disorder) may relate to POMC dysregulation. Autonomic dysfunction (orthostatic hypotension, constipation) involves hypothalamic control. Weight loss and cachexia in PD patients correlate with POMC alterations [6](https://pubmed.ncbi.nlm.nih.gov/20082963/).

Neuroinflammation: POMC peptides modulate neuroinflammation in PD. Elevated cytokines affect hypothalamic POMC neurons. Microglial activation occurs in the hypothalamus of PD patients. alpha-MSH may protect against dopaminergic neuron loss [7](https://pubmed.ncbi.nlm.nih.gov/28742158/).

L-DOPA-induced dyskinesias: Chronic L-DOPA treatment alters hypothalamic function. Cortisol dysregulation occurs in dyskinetic PD patients. Melatonin and POMC interactions affect PD sleep disturbances [8](https://pubmed.ncbi.nlm.nih.gov/25394404/).

Amyotrophic Lateral Sclerosis (ALS)

POMC involvement in ALS:

Metabolic dysfunction: ALS patients show hypermetabolism and weight loss. POMC regulates energy homeostasis and may be affected. Altered leptin and insulin signaling occurs in ALS [9](https://pubmed.ncbi.nlm.nih.gov/32048860/).

Hypothalamic involvement: ALS affects hypothalamic neurons. POMC neuron loss is reported in ALS mouse models. Altered circadian rhythms and neuroendocrine dysfunction occur in ALS patients [10](https://pubmed.ncbi.nlm.nih.gov/26036853/).

Stress response: The HPA axis is dysregulated in ALS with elevated cortisol. Stress may accelerate disease progression and POMC regulates the stress response via ACTH [11](https://pubmed.ncbi.nlm.nih.gov/22982366/).

Therapeutic Implications

Targeting the Melanocortin System

Melanocortin receptor agonists: MC4R agonists are being developed for obesity and potentially for neurodegenerative diseases. Novel small-molecule MC4R agonists may improve energy homeostasis in AD/PD [12](https://pubmed.ncbi.nlm.nih.gov/32840449/).

alpha-MSH analogs: Synthetic alpha-MSH analogs have anti-inflammatory and neuroprotective properties with potential for treating neuroinflammation in AD/PD/ALS.

Metabolic Modulation

Leptin analogs: May improve hypothalamic function in neurodegeneration. Leptin replacement shows promise in improving cognition in animal models and leptin resistance is a therapeutic target [13](https://pubmed.ncbi.nlm.nih.gov/29954775/).

Insulin signaling: Intranasal insulin and insulin sensitizers may improve hypothalamic function and cognition. Being investigated in AD and PD clinical trials [14](https://pubmed.ncbi.nlm.nih.gov/31148255/).

Anti-inflammatory Approaches

Targeting neuroinflammation via POMC: MC1R agonists provide anti-inflammatory effects, modulating microglial activation states and cytokine-targeted therapies.

See Also

• [Hypothalamic Circuits](/cell-types/hypothalamic-circuits)
• [Arcuate Nucleus](/cell-types/arcuate-nucleus)
• [Energy Homeostasis](/mechanisms/energy-homeostasis)
• [Stress Response](/cell-types/stress-response-neurons)
• [HPA Axis](/mechanisms/hypothalamic-pituitary-adrenal-axis)

External Links

• [NeuroNames Database](https://braininfo.rpri.gelhofu.edu/)
• [Allen Brain Atlas](https://celltypes.brain-map.org/)

Background

The study of Proopiomelanocortin Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Pathway Diagram

The following diagram shows the key molecular relationships involving Proopiomelanocortin Neurons discovered through SciDEX knowledge graph analysis: